Psylo

Developer of psychedelic derived therapeutic for mental illness

placeSydney, New South Wales, Australia calendar_todayFounded 2021 groups24 employees language psylo.bio

Registered entities

Innovation

6 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace accelerating. Cited 189 times.

YearFilings
20233
20243
20256
20262

Investor mix

15 investors on record; lead investors include Main Sequence, Tenmile.

Investor typeCountShare
Venture capital1280%
Other / undisclosed320%
Coming soon